REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $6,059,000 | +180.8% | 213,808 | +149.1% | 0.21% | +163.0% |
Q3 2020 | $2,158,000 | +3.0% | 85,840 | 0.0% | 0.08% | +1.2% |
Q2 2020 | $2,096,000 | +65.0% | 85,840 | 0.0% | 0.08% | +40.4% |
Q1 2020 | $1,270,000 | -8.8% | 85,840 | 0.0% | 0.06% | +7.5% |
Q4 2019 | $1,393,000 | -28.0% | 85,840 | +10.2% | 0.05% | -24.3% |
Q3 2018 | $1,936,000 | -9.5% | 77,919 | 0.0% | 0.07% | -13.6% |
Q2 2018 | $2,139,000 | +60.2% | 77,919 | +79.8% | 0.08% | +55.8% |
Q1 2018 | $1,335,000 | +15.9% | 43,329 | +34.5% | 0.05% | +18.2% |
Q4 2017 | $1,152,000 | -5.3% | 32,225 | -57.0% | 0.04% | -6.4% |
Q3 2016 | $1,216,000 | +19.2% | 75,000 | 0.0% | 0.05% | +11.9% |
Q2 2016 | $1,020,000 | +29.8% | 75,000 | +66.7% | 0.04% | +27.3% |
Q1 2016 | $786,000 | – | 45,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |